A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection

Cellular and Molecular Immunology

Volumn 8, Issue 6, 2011, Pages 462-468

  Wang, Xiaohui ^a   Chan, Chris C S ^a   Yang, Min ^a   Deng, Jun ^a   Poon, Vincent K M ^a   Leung, Virtual H C ^a   Ko, King Hung ^a   Zhou, Jie ^a   Yung Yuen, Kwok ^a   Zheng, Bo Jian ^a   Lu, Liwei ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

B cell; H5N1 influenza virus; IL 17; lung infection

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; INTERLEUKIN 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; IMMUNE RESPONSE; INFLUENZA A (H5N1); LUNG INJURY; LUNG PARENCHYMA; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL RATE; WEIGHT REDUCTION;

ANIMALS; B-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINE CXCL13; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; GENE DELETION; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; INTERLEUKIN-17; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, CXCR5; SURVIVAL RATE; WEIGHT LOSS;

FUNGI; MUS; ORTHOMYXOVIRIDAE;

EID: 80055117444     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2011.38     Document Type: Article

References (51)

1. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351: 467-471. (Pubitemid 28070092)
2. Oxford JS. Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology. Rev Med Virol 2000; 10: 119-133. (Pubitemid 30175426)
3. Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008; 371: 1464-1475. (Pubitemid 351618340)
4. Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009; 45: 169-173.
5. Zheng BJ, Chan KW, Lin YP, Zhao GY, Chan C, Zhang HJ et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci USA 2008; 105: 8091-8096. (Pubitemid 351904713)
6. Osterholm MT. Proposed mechanism of the cytokine storm evoked by influenza virus. N Engl J Med 2005; 352: 1839.
7. Lai Kwan Lam Q, King Hung Ko O, Zheng BJ, Lu L. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci USA 2008; 105: 14993-14998.
8. O'Quinn DB, Palmer MT, Lee YK, Weaver CT. Emergence of the Th17 pathway and its role in host defense. Adv Immunol 2008; 99: 115-163.
9. Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, Quinton LJ et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 2005; 202: 761-769. (Pubitemid 41345965)
10. Kohyama S, Ohno S, Isoda A, Moriya O, Belladonna ML, Hayashi H et al. IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17. J Immunol 2007; 179: 3917-3925.
11. Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, Kawakami K et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 2007; 178: 3786-3796. (Pubitemid 46417647)
12. Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, McKinstry KK et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 2009; 182: 3469-3481.
13. McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, Huston G et al. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 2009; 182: 7353-7363.
14. Norton EB, Clements JD, Voss TG, Cardenas-Freytag L. Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model. J Virol 2010; 84: 2983-2995.
15. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141. (Pubitemid 41541791)
16. Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI et al. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 2009; 183: 5301-5310.
17. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009; 13: R201.
18. Kohlmeier JE, Woodland DL. Immunity to respiratory viruses. Annu Rev Immunol 2009; 27: 61-82.
19. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000; 192: 271-280. (Pubitemid 30470309)
20. Harada Y, Muramatsu M, Shibata T, Honjo T, Kuroda K. Unmutated immunoglobulin M can protect mice from death by influenza virus infection. J Exp Med 2003; 197: 1779-1785. (Pubitemid 36745352)
21. Palladino G, Mozdzanowska K, Washko G, Gerhard W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol 1995; 69: 2075-2081.
22. Xie S, Li J, Wang JH, Wu Q, Yang P, Hsu HC et al. IL-17 activates the canonical NF-kappaB signaling pathway in autoimmune B cells of BXD2 mice to upregulate the expression of regulators of G-protein signaling 16. J Immunol 2010; 184: 2289-2296.
23. Algood HM, Allen SS, Washington MK, Peek RM Jr, Miller GG, Cover TL. Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J Immunol 2009; 183: 5837-5846.
24. Mitsdoerffer M, Lee Y, Jager A, Kim HJ, Korn T, Kolls JK et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci USA 2010; 107: 14292-14297.
25. Reed LJ, Muench H. A simple method of estimation fifty percent endpoints. Am J Hyg 1938; 27: 493-497.
26. Sun S, Zhao G, Xiao W, Hu J, Guo Y, Yu H et al. Age-related sensitivity and pathological differences in infections by 2009 pandemic influenza A (H1N1) virus. Virol J 2011; 8: 52.
27. van den Brand JM, Stittelaar KJ, van Amerongen G, Rimmelzwaan GF, Simon J, de Wit E et al. Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis 2010; 201: 993-999.
28. 1 T cells from murine lungs: a method to analyze ongoing immune responses in the lung. Nat Protoc 2006; 1: 2870-2875.
29. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD et al. H5N1 virus attachment to lower respiratory tract. Science 2006; 312: 399
30. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 2007; 13: 147-149.
31. Coro ES, Chang WL, Baumgarth N. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol 2006; 176: 4343-4351. (Pubitemid 44264414)
32. Rothaeusler K, Baumgarth N. B-cell fate decisions following influenza virus infection. Eur J Immunol 2010; 40: 366-377.
33. Ansel KM, Harris RB, Cyster JG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002; 16: 67-76. (Pubitemid 34143217)
34. Hopken UE, Achtman AH, Kruger K, Lipp M. Distinct and overlapping roles of CXCR5 and CCR7 in B-1 cell homing and early immunity against bacterial pathogens. J Leukoc Biol 2004; 76: 709-718. (Pubitemid 39129105)
35. Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 2006; 107: 2613-2618.
36. Ebert LM, Schaerli P, Moser B. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 2005; 42: 799-809. (Pubitemid 40489029)
37. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194: 519-527. (Pubitemid 32835046)
38. Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, Ramsay AJ et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 2003; 170: 4432-4436. (Pubitemid 36519946)
39. Baumgarth N, Choi YS, Rothaeusler K, Yang Y, Herzenberg LA. B cell lineage contributions to antiviral host responses. Curr Top Microbiol Immunol 2008; 319: 41-61.
40. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol 2008; 3: 499-522. (Pubitemid 351488291)
41. Norton EB, Clements JD, Voss TG, Cardenas-Freytag L. Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model. J Virol 2010; 84: 2983-2995.
42. Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, Costantini C et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010; 115: 335-343.
43. Linden A, Laan M, Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur Respir J 2005; 25: 159-172. (Pubitemid 40207746)
44. Rangel-Moreno J, Moyron-Quiroz JE, Hartson L, Kusser K, Randall TD. Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. Proc Natl Acad Sci USA 2007; 104: 10577-10582. (Pubitemid 47185707)
45. Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008; 9: 166-175.
46. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996; 87: 1037-1047. (Pubitemid 26427987)
47. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998; 391: 799-803. (Pubitemid 28099679)
48. Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, Hwang JY, Kusser K, Hartson L et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 2011; 12: 639-646.
49. Hojgaard A, Close R, Dunn DM, Weiss RB, Weis JJ, Weis JH. Altered localization of CXCL13 expressing cells in mice deficient in Pactolus following an inflammatory stimulus. Immunology 2006; 119: 212-223. (Pubitemid 44401640)
50. GeurtsvanKessel CH, Willart MA, Bergen IM, van Rijt LS, Muskens F, Elewaut D et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med 2009; 206: 2339-2349.
51. Liu B, Tan W, Barsoum A, Gu X, Chen K, Huang W et al. IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement. Exp Hematol.2010; 38: 877-884. e1.